The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Intera Oncology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Intera Oncology Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Intera Oncology is a life science company that designs and develops products to improve the lives of patients with colorectal cancer and cholangiocarcinoma. It ensures access to Hepatic Artery Infusion (HAI) therapy to help patients live longer and better lives by changing the course of cancer. The company’s key product, Intera 3000 Hepatic Artery Infusion Pump, a palm-sized, implantable device that delivers a continuous flow of chemotherapy via hepatic artery directly to tumors in the liver. It also develops innovative new solutions for treatment of diseases with significant unmet medical needs. Intera Oncology is headquartered in Wellesley, Massachusetts, the US.

The key metrics of Intera Oncology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Intera Oncology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Intera Oncology.

For a detailed understanding of the performance of Intera Oncology, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.